Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter H van Geffen

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
ERJ Open Research|April 1, 2025
Anti-inflammatory effects of tiotropium in COPD: a randomised double-blind trialLisa H van Smoorenburg, Tatiana Karp, Benedikt Ditz, et al.
Lung Cancer (Amsterdam, Netherlands)|July 7, 2023
Survival of patients with KRAS G12C mutated stage IV non-small cell lung cancer with and without brain metastases treated with immune checkpoint inhibitorsEsther M Swart, Anneloes L Noordhof, Ronald A M Damhuis, et al.
Cancers|June 26, 2026
Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based StudyEline G M Steenhuis, Lieke M van Disseldorp, Femke J C Jacobs, et al.
Respiration; International Review of Thoracic Diseases|June 26, 2019
Quantitative Evaluation of Lobar Pulmonary Function of Emphysema Patients with Endobronchial CoilsMali Shen, Eric D Tenda, William McNulty, et al.
Breathe (Sheffield, England)|December 6, 2019
Continuous professional development: elevating thoracic oncology education in EuropeWouter H van Geffen, Torsten G Blum, Stefano Aliberti, et al.
Lung Cancer (Amsterdam, Netherlands)|March 10, 2026
Volume and location of screen-detected lung nodules associated with lung cancer within two-year follow-up: Post hoc analysis from the UK Lung Cancer Screening (UKLS) trialOke Dimas Asmara, Harriet L Lancaster, John K Field, et al.
Chest|October 15, 2022
Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose: A Multicenter Validation StudySharina Kort, Marjolein Brusse-Keizer, Hugo Schouwink, et al.
Cancer Chemotherapy and Pharmacology|November 6, 2025
Optimizing lazertinib therapy through GSTM1 genotyping: a strategy to reduce excess drug exposure and potential toxicityRob Ter Heine, Bianca J C van den Bosch, Robin M van Geel, et al.
Lung Cancer (Amsterdam, Netherlands)|December 31, 2025
Effect of treatment sequencing on outcome of patients with non-small cell lung cancer with a synchronous solitary extrathoracic metastasisMandy Jongbloed, Ronald A M Damhuis, Wouter H Van Geffen, et al.
Lung Cancer (Amsterdam, Netherlands)|February 20, 2026
Patterns of progression in patients with synchronous oligometastatic non-small cell lung cancer after systemic and local radical treatmentValentina Bartolomeo, Mandy Jongbloed, Jarno W J Huijs, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
ERJ Open Research|April 1, 2025
Anti-inflammatory effects of tiotropium in COPD: a randomised double-blind trialLisa H van Smoorenburg, Tatiana Karp, Benedikt Ditz, et al.
Lung Cancer (Amsterdam, Netherlands)|July 7, 2023
Survival of patients with KRAS G12C mutated stage IV non-small cell lung cancer with and without brain metastases treated with immune checkpoint inhibitorsEsther M Swart, Anneloes L Noordhof, Ronald A M Damhuis, et al.
Cancers|June 26, 2026
Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based StudyEline G M Steenhuis, Lieke M van Disseldorp, Femke J C Jacobs, et al.
Respiration; International Review of Thoracic Diseases|June 26, 2019
Quantitative Evaluation of Lobar Pulmonary Function of Emphysema Patients with Endobronchial CoilsMali Shen, Eric D Tenda, William McNulty, et al.
Breathe (Sheffield, England)|December 6, 2019
Continuous professional development: elevating thoracic oncology education in EuropeWouter H van Geffen, Torsten G Blum, Stefano Aliberti, et al.
Lung Cancer (Amsterdam, Netherlands)|March 10, 2026
Volume and location of screen-detected lung nodules associated with lung cancer within two-year follow-up: Post hoc analysis from the UK Lung Cancer Screening (UKLS) trialOke Dimas Asmara, Harriet L Lancaster, John K Field, et al.
Chest|October 15, 2022
Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose: A Multicenter Validation StudySharina Kort, Marjolein Brusse-Keizer, Hugo Schouwink, et al.
Cancer Chemotherapy and Pharmacology|November 6, 2025
Optimizing lazertinib therapy through GSTM1 genotyping: a strategy to reduce excess drug exposure and potential toxicityRob Ter Heine, Bianca J C van den Bosch, Robin M van Geel, et al.
Lung Cancer (Amsterdam, Netherlands)|December 31, 2025
Effect of treatment sequencing on outcome of patients with non-small cell lung cancer with a synchronous solitary extrathoracic metastasisMandy Jongbloed, Ronald A M Damhuis, Wouter H Van Geffen, et al.
Lung Cancer (Amsterdam, Netherlands)|February 20, 2026
Patterns of progression in patients with synchronous oligometastatic non-small cell lung cancer after systemic and local radical treatmentValentina Bartolomeo, Mandy Jongbloed, Jarno W J Huijs, et al.
Pageof 7